Literature DB >> 34859129

Quantification of Duloxetine in the Bacterial Culture and Medium to Study Drug-gut Microbiome Interactions.

Prasad B Phapale1, Sonja Blasche1, Kiran R Patil1, Theodore Alexandrov1,2.   

Abstract

Expanding our understanding of drug-gut bacteria interactions requires high-throughput drug measurements in complex bacterial cultures. Quantification of drugs in the cultures, media, and cell pellets is prone to strong matrix effects. We have developed a liquid chromatography-high resolution mass spectrometry (LC-HRMS) method for quantifying duloxetine from high-throughput gut-drug interaction experiments. The method is partially validated for its reproducibility, sensitivity, and accuracy, which makes it suitable for largescale drug screens. We extensively used this method to study biotransformation and bioaccumulation of duloxetine and other drugs in several species of gut bacteria.
Copyright © 2021 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Bioaccumulation; Biotransformation; Drug quantification; Drug-gut interactions; LC–HRMS; LC–MS/MS

Year:  2021        PMID: 34859129      PMCID: PMC8595414          DOI: 10.21769/BioProtoc.4214

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  11 in total

1.  Population-level analysis of gut microbiome variation.

Authors:  Gwen Falony; Marie Joossens; Sara Vieira-Silva; Jun Wang; Youssef Darzi; Karoline Faust; Alexander Kurilshikov; Marc Jan Bonder; Mireia Valles-Colomer; Doris Vandeputte; Raul Y Tito; Samuel Chaffron; Leen Rymenans; Chloë Verspecht; Lise De Sutter; Gipsi Lima-Mendez; Kevin D'hoe; Karl Jonckheere; Daniel Homola; Roberto Garcia; Ettje F Tigchelaar; Linda Eeckhaudt; Jingyuan Fu; Liesbet Henckaerts; Alexandra Zhernakova; Cisca Wijmenga; Jeroen Raes
Journal:  Science       Date:  2016-04-28       Impact factor: 47.728

2.  Curatr: a web application for creating, curating and sharing a mass spectral library.

Authors:  Andrew Palmer; Prasad Phapale; Dominik Fay; Theodore Alexandrov
Journal:  Bioinformatics       Date:  2018-04-15       Impact factor: 6.937

Review 3.  Systematically investigating the impact of medication on the gut microbiome.

Authors:  Lisa Maier; Athanasios Typas
Journal:  Curr Opin Microbiol       Date:  2017-10       Impact factor: 7.934

4.  Bioaccumulation of therapeutic drugs by human gut bacteria.

Authors:  Martina Klünemann; Sergej Andrejev; Sonja Blasche; Andre Mateus; Prasad Phapale; Saravanan Devendran; Johanna Vappiani; Bernd Simon; Timothy A Scott; Eleni Kafkia; Dimitrios Konstantinidis; Katharina Zirngibl; Eleonora Mastrorilli; Manuel Banzhaf; Marie-Therese Mackmull; Felix Hövelmann; Leo Nesme; Ana Rita Brochado; Lisa Maier; Thomas Bock; Vinita Periwal; Manjeet Kumar; Yongkyu Kim; Melanie Tramontano; Carsten Schultz; Martin Beck; Janosch Hennig; Michael Zimmermann; Daniel C Sévin; Filipe Cabreiro; Mikhail M Savitski; Peer Bork; Athanasios Typas; Kiran R Patil
Journal:  Nature       Date:  2021-09-08       Impact factor: 49.962

5.  Determination of duloxetine in human plasma by liquid chromatography with atmospheric pressure ionization-tandem mass spectrometry and its application to pharmacokinetic study.

Authors:  P Senthamil Selvan; K Veeran Gowda; U Mandal; W D Sam Solomon; T K Pal
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-09-14       Impact factor: 3.205

6.  Measurement of duloxetine in blood using high-performance liquid chromatography with spectrophotometric detection and column switching.

Authors:  Christine Waldschmitt; Friederike Vogel; Christian Maurer; Christoph Hiemke
Journal:  Ther Drug Monit       Date:  2007-12       Impact factor: 3.681

7.  Quantitative determination of duloxetine and its metabolite in rat plasma by HPLC-MS/MS.

Authors:  Jung-woo Chae; Hyun-moon Baek; Sang Kyum Kim; Ho-il Kang; Kwang-il Kwon
Journal:  Biomed Chromatogr       Date:  2013-03-21       Impact factor: 1.902

8.  Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.

Authors:  Kristoffer Forslund; Falk Hildebrand; Trine Nielsen; Gwen Falony; Emmanuelle Le Chatelier; Shinichi Sunagawa; Edi Prifti; Sara Vieira-Silva; Valborg Gudmundsdottir; Helle K Pedersen; Manimozhiyan Arumugam; Karsten Kristiansen; Anita Yvonne Voigt; Henrik Vestergaard; Rajna Hercog; Paul Igor Costea; Jens Roat Kultima; Junhua Li; Torben Jørgensen; Florence Levenez; Joël Dore; H Bjørn Nielsen; Søren Brunak; Jeroen Raes; Torben Hansen; Jun Wang; S Dusko Ehrlich; Peer Bork; Oluf Pedersen
Journal:  Nature       Date:  2015-12-02       Impact factor: 49.962

9.  Mapping human microbiome drug metabolism by gut bacteria and their genes.

Authors:  Michael Zimmermann; Maria Zimmermann-Kogadeeva; Rebekka Wegmann; Andrew L Goodman
Journal:  Nature       Date:  2019-06-03       Impact factor: 49.962

10.  Host-Microbe Co-metabolism Dictates Cancer Drug Efficacy in C. elegans.

Authors:  Timothy A Scott; Leonor M Quintaneiro; Povilas Norvaisas; Prudence P Lui; Matthew P Wilson; Kit-Yi Leung; Lucia Herrera-Dominguez; Sonia Sudiwala; Alberto Pessia; Peter T Clayton; Kevin Bryson; Vidya Velagapudi; Philippa B Mills; Athanasios Typas; Nicholas D E Greene; Filipe Cabreiro
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.